Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 6 EP applications Julia Hackenberg has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 08, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP15730959

NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61P 21/00, A61K 38/48
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP15731248

NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61K 38/16, A61P 21/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP15730689

USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERS

IPC classification:
A61P 21/02, A61K 38/48
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP15729755

NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61P 19/00, A61P 21/00, A61K 38/16
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP16202580

NOVEL RECOMBINANT BOTULINUM TOXIN WITH ACCELARATED ONSET OF EFFECT

IPC classification:
C07K 14/33
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
The application has been published
EP16204038

NOVEL RECOMBINANT BOTULINUM NEUROTOXINS WITH A STABILIZED LIGHT CHAIN

IPC classification:
C12N 9/52, C07K 14/33, A61K 38/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
The application has been published

Please Sign in to use this feature